ClearAlpha Technologies »

Cerevel Therapeutics Hldng I shares owned by ClearAlpha Technologies

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by ClearAlpha Technologies from 13F filings

Historical chart of ClearAlpha Technologies investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by ClearAlpha Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by ClearAlpha Technologies

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5M 35k 42.40

More positions owned by ClearAlpha Technologies

Hess (HES)
Pioneer Natural Resources (PXD)
stock
Albertsons Cos Common Stock (ACI)
Capri Holdings SHS (CPRI)
Endeavor Group Hldgs Cl A Com Put Option (EDR)
Amedisys (AMED)
Sovos Brands
Rover Group Com Cl A
Fox Corp Cl A Com (FOXA)
ImmunoGen
MGIC Investment (MTG)
Goldman Sachs (GS)
Loews Corporation (L)
Taylor Morrison Hom (TMHC)

View all positions for ClearAlpha Technologies

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I